• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Innoviva, Inc. - Common Stock (NQ:INVA)

20.50 -0.05 (-0.24%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 774,707
Open 20.60
Bid (Size) 20.20 (200)
Ask (Size) 20.80 (300)
Prev. Close 20.55
Today's Range 20.50 - 20.76
52wk Range 16.52 - 25.14
Shares Outstanding 65,504,384
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Innoviva (NASDAQ:INVA) Fits the Affordable Growth Mold ↗
September 25, 2026
Via Chartmill
Innoviva (NASDAQ:INVA): An Undervalued Value Stock Backed by Strong Cash Flow ↗
September 17, 2026
Via Chartmill

Performance

52-Week Range 18.5% below 52-week high
20.50
16.5252W Low 25.1452W High
1 Week 4.4% below 1-week high
20.501W Low 21.451W High

Innoviva, Inc. - Common Stock (INVA) traded between $16.52 and $25.14 over the past 52 weeks and last traded at $20.50, 18.5% below its 52-week high. Over the past week it ranged between $20.50 and $21.45.

Past 12 Months
-3.4%
-4.0%
-6.0%
-10.9%
+3.2%
+16.1%
1W -$0.73
1M -$0.85
3M -$1.32
6M -$2.52
YTD +$0.63
1Y +$2.84

INVA was +16.1% over the past year, -10.9% over six months, +3.2% year to date, -3.4% in the last week.

12 Months vs Market
INVA
+16.1%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months INVA returned +16.1% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 0.94× 3-mo avg
Today 774,707 3-mo avg 824.5K
1W
842.5K
1M
1.0M
3M
824.5K
6M
801.1K
YTD
790.9K
1Y
812.8K

INVA most recently traded 774,707 shares against a 3-month average daily volume of 824.5K.

More News

Read More
News headline image
Innoviva to Participate in Upcoming Investor Conferences
September 02, 2026
From Innoviva, Inc.
Via Business Wire
News headline image
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
August 11, 2026
From Innoviva Specialty Therapeutics
Via Business Wire
News headline image
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
August 05, 2026
From Innoviva, Inc.
Via Business Wire
Innoviva (INVA): Affordable Growth Stock at a Reasonable Valuation ↗
July 28, 2026
Via Chartmill
Innoviva Inc (NASDAQ:INVA): A Decent Value Play with Strong Fundamentals ↗
July 07, 2026
Via Chartmill
INNOVIVA INC (NASDAQ:INVA): A Strong Growth Stock Poised for a Technical Breakout ↗
June 27, 2026
Via Chartmill
Innoviva Inc (NASDAQ:INVA): A GARP Standout with 470% EPS Growth and a P/E of Just 6.05 ↗
June 18, 2026
Via Chartmill
News headline image
Nortiva Bio Launches to Develop Long-Acting Oral Medicines
June 18, 2026
From Nortiva Bio, Inc.
Via Business Wire
News headline image
Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets
June 16, 2026
From Innoviva Specialty Therapeutics
Via Business Wire
News headline image
Innoviva to Participate in Upcoming Investor Conferences
June 01, 2026
From Innoviva, Inc.
Via Business Wire
News headline image
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More ↗
May 29, 2026
Via The Motley Fool
Topics Regulatory Compliance
INNOVIVA INC (NASDAQ:INVA) Scores as a Value Stock with Strong Fundamentals ↗
May 25, 2026
Via Chartmill
Innoviva Inc (NASDAQ:INVA) Screened as a Top Value Stock with Strong Fundamentals ↗
April 04, 2026
Via Chartmill
News headline image
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress
May 06, 2026
From Innoviva, Inc.
Via Business Wire
News headline image
3 Bargain-Cheap Small Caps Worth a Second Look ↗
April 09, 2026
Via MarketBeat
News headline image
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential ↗
March 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
INNOVIVA INC (NASDAQ:INVA) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template ↗
March 02, 2026
Via Chartmill
Innoviva Inc (NASDAQ:INVA) Presents a Compelling Value Investment Case ↗
February 10, 2026
Via Chartmill
News headline image
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
February 25, 2026
From Innoviva, Inc.
Via Business Wire
News headline image
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
From Innoviva, Inc.
Via Business Wire
News headline image
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out ↗
January 08, 2026
Via MarketBeat
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
December 16, 2025
Via Chartmill
News headline image
U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
December 12, 2025
From Innoviva, Inc.
Via Business Wire

Frequently Asked Questions

Is Innoviva, Inc. - Common Stock publicly traded?
Yes, Innoviva, Inc. - Common Stock is publicly traded.
What exchange does Innoviva, Inc. - Common Stock trade on?
Innoviva, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Innoviva, Inc. - Common Stock?
The ticker symbol for Innoviva, Inc. - Common Stock is INVA on the Nasdaq Stock Market
What is the current price of Innoviva, Inc. - Common Stock?
The current price of Innoviva, Inc. - Common Stock is 20.50
When was Innoviva, Inc. - Common Stock last traded?
The last trade of Innoviva, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of Innoviva, Inc. - Common Stock?
The market capitalization of Innoviva, Inc. - Common Stock is 1.34B
How many shares of Innoviva, Inc. - Common Stock are outstanding?
Innoviva, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap